Skip to content

RCT of BLT Implants Used for Immediate vs Early Placement, Restored With Ceramic Crowns on Titanium Bonding Bases.

Randomized Controlled Clinical Trial of BLT Implants Used for Immediate vs Early Placement and Restored With Lithium-disilicate Glass Ceramic or Sintered Zirconia Crowns on Titanium Bonding Bases.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05079542
Acronym
BLT
Enrollment
60
Registered
2021-10-15
Start date
2015-10-05
Completion date
2025-03-03
Last updated
2021-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Single-tooth, Tooth Loss

Keywords

immediate implant placement, delayed implant placement, all-ceramic crown, monolithic restoration, titanium base

Brief summary

The purpose of this study is to assess the outcome of a new bone level tapered implant when inserted either following an immediate placement protocol or an early placement approach and restored with single crowns out of two different ceramic materials adhesively cemented on a titanium bonding base.

Interventions

PROCEDURETimepoint of Implant placement of Bonelevel tapered implants

Implant surgery on different time points

COMBINATION_PRODUCTMaterial for tooth restoration - Lithiumdisilicate glass ceramic or zirconia

Tooth restoration with a certain material

Sponsors

University of Geneva, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

In the first phase, participants are randomized to receive implants either immediately or 8 weeks after tooth extraction. In a second phase, participants receive either a restoration out of one material or another, this also being randomized.

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Subjects must require extraction and replacement of a tooth in the maxillary or mandibular anterior or premolar region with an implant reconstruction. * ≥22 years of age * Patient in a good general health * Adequate bone quality and quantity for one-stage implant placement * Patient with physical status PS1 and PS2 (according to Physical Status Classification System of the American Society of Anesthesiologists; Attachment 5) * Adequate bone height of at least 1mm longer than the length of the study implant * Capable of providing written informed consent. * Obtained informed consent from the patient and committed to the study and the required follow-up visits.

Exclusion criteria

* Patients with a high lip line / smile line * Thin mucosal biotype * Anatomically not sufficient bone volume or height at implant site to achieve primary stability of the implant * Pronounced esthetic expectations * Lack of keratinized mucosa at implant site (\< 2mm oral and buccal) * Women of childbearing potential with a positive urine pregnancy test * Patients with inadequate oral hygiene or persistent intraoral infection * Smokers exceeding 10 cigarettes / day, or equivalent; patients chewing tobacco * Severe bruxism or clenching habits * Presence a systemic disease or allergy (e.g. conditions requiring chronic routine prophylactic use of antibiotics or prolonged use of steroids, history of rheumatic heart disease, bacterial endocarditis, cardiac vascular anomalies, prosthetic joint replacements, etc.) * Presence or history of receiving intravenous or subcutaneous antiresorptive agents, such as bisphosphonates * Presence of mucosal diseases (e.g. erosive lichen planus) in the localized area around the study implant * Patients with history of renal failure, bleeding disorders, metabolic bone disorder, uncontrolled endocrine disorders, HIV infection, leucocyte dysfunction and deficiencies, neoplastic disease requiring the use of radiation or chemotherapy, etc. * Patients with alcohol or drug abuse * Participation in any other clinical trial (drug or device) less that 30 days before implant insertion

Design outcomes

Primary

MeasureTime frameDescription
Implant survival5 yearsSurvival of the implant
Survival of the reconstructions5 yearsSurvival of prosthetic reconstruction

Secondary

MeasureTime frameDescription
Soft tissue volume5 yearsIntra-oral digital scans with volumetric software will be used for the soft tissue volume measurements.
Mesial and distal bone levels5 yearsPeri-implant bone level changes
Recording the need of GBR procedures8 weeksNeed of GBR procedure or not during surgery
Technical and biological outcomes of the restorations5 yearsPresence of fractures/chipping, retention loss, screw loosening
ISQ values3 monthsMeasurement of ISQ values during implant surgery and at insertion of crown

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026